Nattarin Polpuech - Inter Pharma CFO Fin

All Insiders . Thailand . 
Stock . Inter Pharma Public . Stakeholders . Insider . Nattarin Polpuech
IP Stock  THB 3.60  0.04  1.10%   

Insider

Nattarin Polpuech is CFO Fin of Inter Pharma Public
Phone66 2 634 0225
Webhttps://www.interpharma.co.th

Inter Pharma Management Efficiency

The company has return on total asset (ROA) of 0.0524 % which means that it generated a profit of $0.0524 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1031 %, meaning that it generated $0.1031 on every $100 dollars invested by stockholders. Inter Pharma's management efficiency ratios could be used to measure how well Inter Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Inter Pharma Public has accumulated 187.06 M in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. Inter Pharma Public has a current ratio of 2.55, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Inter Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Inter Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inter Pharma Public sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inter to invest in growth at high rates of return. When we think about Inter Pharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Nattawat PhetthaiDOD Biotech Public
32
Deepak PanjwaniMega Lifesciences Public
49
Suntharee NoinartIntermedical Care and
N/A
Torlarp ChaiyachowDOD Biotech Public
N/A
Chatrchai TuongratanaphanDohome Public
62
Isara RujikeatkamjornSiam Global House
43
Khemchat SungkakamSiam Global House
40
Kriangkai SuriyawanakulSiam Global House
34
Maruay TangmitrphrachaDohome Public
31
Ratchaneeporn MokkarawutIntermedical Care and
42
Jintana KoontaweeDohome Public
44
Sittiwat KamkatwongIntermedical Care and
46
Adisak TangmitrphrachaDohome Public
69
Tarin ThaniyavarnDohome Public
34
Chutikan SrisaengchanSiam Global House
53
Pornsiri LoesprapapornDohome Public
39
Duangnapa TongsiriMega Lifesciences Public
63
Siriluck RahongIntermedical Care and
N/A
Sopawadee LertmanaschaiDohome Public
66
Thanin SrisethiDOD Biotech Public
44
Anavat SuriyawanakulSiam Global House
63
Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand. Inter Pharma Public (IP) is traded on Thailand Exchange in Thailand and employs 5 people.

Management Performance

Return On Equity0.1
Return On Asset0.0524

Inter Pharma Public Leadership Team

Elected by the shareholders, the Inter Pharma's board of directors comprises two types of representatives: Inter Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inter. The board's role is to monitor Inter Pharma's management team and ensure that shareholders' interests are well served. Inter Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inter Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Trinnawat Thanitnithiphan, CEO Director
Nattarin Polpuech, CFO Fin
Napaporn Dechakarat, Director Director
Chompunuch Meevang, Company Sec
Apimon Posri, HR Director

Inter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inter Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.1
Return On Asset0.0524
Profit Margin0.09 %
Operating Margin0.13 %
Current Valuation4.5 B
Shares Outstanding372.52 M
Shares Owned By Insiders47.33 %
Shares Owned By Institutions2.72 %
Price To Earning115.05 X
Price To Book2.69 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Inter Stock

Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY